En Masse Excision and Curettage for Periarticular Gouty Tophi of the Hands
- PMID: 36000011
- PMCID: PMC9361386
En Masse Excision and Curettage for Periarticular Gouty Tophi of the Hands
Abstract
Background: Despite increasing disease prevalence, there remains a paucity of data examining surgical treatments for gouty tophi. This article assesses en masse excision and curettage of articular tophi involving the hands and shows that carefully planned and precisely executed surgery can consistently alleviate pain, preserve function, and enhance the aesthetics of afflicted hands.
Methods: A retrospective review was conducted of all consecutive patients who underwent surgical excision of tophaceous deposits from the upper extremity. All patients had an established diagnosis of gout and had been treated with urate-lowering medication. All tophi were substantive in size and were causing significant digital joint dysfunction and disfigurement with variable skin ulcerations.
Results: The study group included 12 patients with 24 tophaceous deposits excised from the metacarpal and interphalangeal joints; 2 deposits were also concomitantly excised from the wrist and 2 from the elbow. The study group included 8 men and 4 women, with an average age of 67 years. Follow-up evaluation ranged from 2 to 15 years. All patients underwent successful tophus excision with restoration of tendon excursion and joint mobility without wound complications. All regained high levels of function, and all reported satisfaction with their outcome. On follow-up for as long as 15 years, recurrence has not been observed and secondary surgery has not proved necessary.
Conclusions: This study indicates that surgical excision of articular tophi of the hands can provide long-term improvement in function and aesthetics with minimal risk of wound complications or recurrence.
Keywords: gout; hand; tophi.
© 2022, HMP Global. All rights reserved. Reproduction in whole or in part prohibited. Content may not be reproduced in any form without written permission. Rights, Permission, Reprint, and Translation information is available at www.hmpglobal.com.
Figures




Similar articles
-
Operative management of gouty tophi in the region of the olecranon: a case series.JSES Int. 2022 Feb 23;6(3):550-554. doi: 10.1016/j.jseint.2022.02.003. eCollection 2022 May. JSES Int. 2022. PMID: 35572418 Free PMC article.
-
First metatarsophalangeal joint arthrodesis for the treatment of tophaceous gouty arthritis.Orthopedics. 2014 Feb;37(2):e141-7. doi: 10.3928/01477447-20140124-15. Orthopedics. 2014. PMID: 24679199
-
Limited knee joint range of motion due to invisible gouty tophi.Rheumatology (Oxford). 2004 Feb;43(2):191-4. doi: 10.1093/rheumatology/keg478. Epub 2003 Aug 29. Rheumatology (Oxford). 2004. PMID: 12949254
-
Treatment of tophaceous gout: When medication is not enough.Semin Arthritis Rheum. 2016 Jun;45(6):669-74. doi: 10.1016/j.semarthrit.2016.01.005. Epub 2016 Jan 29. Semin Arthritis Rheum. 2016. PMID: 26947439 Review.
-
Evidence review for surgical excision of tophi: Gout: diagnosis and management: Evidence review O.London: National Institute for Health and Care Excellence (NICE); 2022 Jun. London: National Institute for Health and Care Excellence (NICE); 2022 Jun. PMID: 36063468 Free Books & Documents. Review.
Cited by
-
Establishment and Validation of Predictive Model of Tophus in Gout Patients.J Clin Med. 2023 Feb 22;12(5):1755. doi: 10.3390/jcm12051755. J Clin Med. 2023. PMID: 36902542 Free PMC article.
References
-
- Kasper IR, Juriga MD, Giurini JM, Shmerling RH. Treatment of tophaceous gout: When medication is not enough. Semin Arthritis Rheum. 2016;45(6):669-674. doi:10.1016/j.semarthrit.2016.01.00510.1016/j.semarthrit.2016.01.005 - DOI - DOI - PubMed
-
- Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin North Am. 2014;40(2):155-175. doi:10.1016/j.rdc.2014.01.00110.1016/j.rdc.2014.01.001 - DOI - DOI - PMC - PubMed
-
- Khanna PP, Nuki G, Bardin T, et al. . Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual Life Outcomes. 2012;10:117. Published 2012 Sep 22. doi:10.1186/1477-7525-10-11710.1186/1477-7525-10-117 - DOI - DOI - PMC - PubMed
-
- Khanna D, Fitzgerald JD, Khanna PP, et al. . 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64(10):1431-1446. doi:10.1002/acr.2177210.1002/acr.21772 - DOI - DOI - PMC - PubMed
-
- Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum. 2002;47(4):356-360. doi:10.1002/art.1051110.1002/art.10511 - DOI - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials